Literature DB >> 9493278

Ocular side effects of amiodarone.

M Mäntyjärvi1, K Tuppurainen, K Ikäheimo.   

Abstract

Amiodarone is an effective antiarrhythmic agent. During therapy, intracytoplasmic lamellar deposits occur in the cornea, lens, retina, and optic nerve. The most common symptom, reported by 1.4-40.0% of patients, is colored rings around lights. The most common ocular finding is corneal epithelial opacities resembling a cat's whiskers in 70-100% of patients; however, lens opacities have been reported in 50-60% of patients. Neither type of deposit impairs visual acuity, and their presence is not contraindicative to continued amiodarone treatment. Retinopathy has, rarely, been reported in association with amiodarone treatment. Optic neuropathy in patients receiving the drug for various lengths of time has been reported as having incidences of 1.3% during the preceding 8 years and 1.76% during the preceding 10 years. Although a causal relationship is not well established, if optic neuropathy is observed, discontinuing or reducing the medication, if not life threatening, should be considered.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9493278     DOI: 10.1016/s0039-6257(97)00118-5

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  26 in total

Review 1.  Ocular adverse effects associated with systemic medications : recognition and management.

Authors:  Ricardo M Santaella; Frederick W Fraunfelder
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Behaviour of disc oedema during and after amiodarone optic neuropathy: case report.

Authors:  Med Alejandro Martínez-LóPez-Portillo; Bertha O Martínez-Gamero; Jibran Mohamed-Noriega; Med Humberto Cavazos-Adame; Med Jesús Mohamed-Hamsho
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 3.  Amiodarone-associated optic neuropathy: a critical review.

Authors:  Rod S Passman; Charles L Bennett; Joseph M Purpura; Rashmi Kapur; Lenworth N Johnson; Dennis W Raisch; Dennis P West; Beatrice J Edwards; Steven M Belknap; Dustin B Liebling; Mathew J Fisher; Athena T Samaras; Lisa-Gaye A Jones; Katrina-Marie E Tulas; June M McKoy
Journal:  Am J Med       Date:  2012-03-03       Impact factor: 4.965

Review 4.  Amiodarone-Associated Optic Neuropathy: Clinical Review.

Authors:  An-Guor Wang; Hui-Chen Cheng
Journal:  Neuroophthalmology       Date:  2016-11-18

5.  Amiodarone-associated Optic Neuropathy-A Clinical Criteria-based Diagnosis?

Authors:  Katrin Fasler; Ghislaine L Traber; Gregor Peter Jaggi; Klara Landau
Journal:  Neuroophthalmology       Date:  2017-08-18

Review 6.  The clinical spectrum of amiodarone-associated optic neuropathy.

Authors:  Lenworth N Johnson; Gregory B Krohel; Eric R Thomas
Journal:  J Natl Med Assoc       Date:  2004-11       Impact factor: 1.798

7.  Amiodarone induced optic neuropathy.

Authors:  P K Nagra; R Foroozan; P J Savino; I Castillo; R C Sergott
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

8.  Clinical applications of corneal confocal microscopy.

Authors:  Mitra Tavakoli; Parwez Hossain; Rayaz A Malik
Journal:  Clin Ophthalmol       Date:  2008-06

Review 9.  Managing atrial fibrillation in the elderly: critical appraisal of dronedarone.

Authors:  Paula Trigo; Gregory W Fischer
Journal:  Clin Interv Aging       Date:  2011-12-30       Impact factor: 4.458

10.  Crystalline-like keratopathy after intravenous immunoglobulin therapy with incomplete kawasaki disease: case report and literature review.

Authors:  Elif Erdem; Emine Kocabas; Hande Taylan Sekeroglu; Ozlem Ozgür; Meltem Yagmur; T Reha Ersoz
Journal:  Case Rep Ophthalmol Med       Date:  2013-03-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.